Sempra’s Q2 Earnings Beat Street. The Revenue Miss Didn’t Matter.
Sempra (SRE) reported Q2 2026 adjusted EPS of $1.16, above the $1.06 Street estimate, while revenue fell to $2.997B versus $3.12B expected. Management kept 2026 adjusted EPS guidance at $4.80 to $5.30 and 2027 at $5.10 to $5.70. The article highlights Texas earnings growth and Oncor’s Batch Zero pipeline.
How this was made
The 30-second read
Why it matters
Traders can reassess near-term expectations using the affirmed 2026 and 2027 EPS ranges, while separately pricing longer-dated optionality from Oncor’s Batch Zero eligible interconnection requests and the balance-sheet impact from the SI Partners stake sale.
Market read
A concrete earnings/guidance print plus specific Texas and Oncor pipeline details can drive repricing, especially for investors focused on regulated rate-base compounding.
What to watch
ECA LNG Phase 1 compressor damage pushed substantial completion into Q4, which could reintroduce execution risk even if investors initially shrugged.
Background
The piece frames Sempra’s Q2 as an EPS beat driven by regulated Texas earnings and rate-case dynamics, despite a revenue shortfall.
Ticker impact
Sempra reported Q2 adjusted EPS of $1.16 vs $1.06 Street and affirmed 2026 EPS guidance of $4.80 to $5.30.
Near-term bias positive if investors buy the Texas growth narrative; upside may be capped until Batch Zero converts into rate-base/capital plan.
The article provides fresh, decision-relevant disclosures (EPS beat, affirmed guidance, Oncor Batch Zero 44 GW eligible requests, and SI Partners stake sale debt reduction). However, it is still partly valuation/model framing and not a new executed contract or regulatory approval.
Market effects
Reinforces the regulated-utility read-through that Texas rate-base expansion can offset revenue softness, supporting sector multiple stability.
Highlights ERCOT/Oncor interconnection demand (Batch Zero) as a potential driver of Texas utility earnings power.
Limited, as the catalysts are primarily US regulated utility and ERCOT grid processes.
Counterpoint
The revenue miss and the fact that Batch Zero upside is not yet in the capital plan could mean the market is over-discounting future rate-base growth.
Key entities
- companySempra
Reported Q2 2026 adjusted EPS beat, held full-year 2026 and 2027 EPS guidance, and discussed Texas rate-base growth drivers.
- operating_subsidiaryOncor
ERCOT Batch Zero process identified 44 GW of eligible large-load interconnection requests that could expand peak load.
- transaction_counterpartySI Partners
Sale of a 45% stake in SI Partners is described as closing this quarter, deconsolidating over $9B of debt.
- market_operatorERCOT
Batch Zero process identified eligible interconnection requests on Oncor’s system.
- credit_rating_agencyMoody’s
CFO referenced targeting a 50 to 150 bps cushion above Moody’s thresholds after the SI Partners sale.
